Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010–2018

Title: Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010–2018
Authors: Tali Wagner; Neta S. Zuckerman; Tami Halperin; Daniel Chemtob; Itzchak Levy; Daniel Elbirt; Eduardo Shachar; Karen Olshtain-Pops; Hila Elinav; Michal Chowers; Valery Itsomin; Klaris Riesenberg; Marina Wax; Rachel Shirazi; Yael Gozlan; Natasha Matus; Shirley Girshengorn; Rotem Marom; Ella Mendelson; Dan Turner; Orna Mor
Source: Viruses, Vol 14, Iss 71, p 71 (2021)
Publisher Information: MDPI AG
Publication Year: 2021
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: epidemiology; people living with HIV-1(PLHIV); HIV-1 spread; transmitted drug-resistance mutations (TDRM); Microbiology; QR1-502
Description: Despite the low prevalence of HIV-1 in Israel, continuous waves of immigration may have impacted the local epidemic. We characterized all people diagnosed with HIV-1 in Israel in 2010–2018. The demographics and clinical data of all individuals ( n = 3639) newly diagnosed with HIV-1 were retrieved. Subtypes, transmitted drug-resistance mutations (TDRM), and phylogenetic relations, were determined in >50% of them. In 39.1%, HIV-1 transmission was through heterosexual contact; 34.3% were men who have sex with men (MSM); and 10.4% were people who inject drugs. Many (>65%) were immigrants. Israeli-born individuals were mostly (78.3%) MSM, whereas only 9% of those born in Sub-Saharan Africa (SSA), Eastern Europe and Central Asia (EEU/CA), were MSM. The proportion of individuals from SSA decreased through the years 2010–2018 (21.1% in 2010–2012; 16.8% in 2016–2018) whereas those from EEU/CA increased significantly (21% in 2010–2012; 27.8% in 2016–2018, p < 0.001). TDRM were identified in 12.1%; 3.7, 3.3 and 6.6% had protease inhibitors (PI), nucleotide reverse transcriptase inhibitors (NRTI), and non-nucleoside reverse transcriptase inhibitors (NNRTI) TDRM, respectively, with the overall proportion remaining stable in the studied years. None had integrase TDRM. Subtype B was present in 43.9%, subtype A in 25.2% (A6 in 22.8 and A1 in 2.4%) and subtype C in 17.1% of individuals. Most MSM had subtype B. Subtype C carriers formed small clusters (with one unexpected MSM cluster), A1 formed a cluster mainly of locally-born patients with NNRTI mutations, and A6 formed a looser cluster of individuals mainly from EEU. Israelis,
Document Type: article in journal/newspaper
Language: English
Relation: https://www.mdpi.com/1999-4915/14/1/71; https://doaj.org/toc/1999-4915; https://doaj.org/article/c746664b673a41488fbb0f4b1e79a623
DOI: 10.3390/v14010071
Availability: https://doi.org/10.3390/v14010071; https://doaj.org/article/c746664b673a41488fbb0f4b1e79a623
Accession Number: edsbas.4028F159
Database: BASE